Transcription of Proposal for the inclusion of mesna (sodium 2 ...
{{id}} {{{paragraph}}}
Example: stock market
Proposal for the inclusion of mesna (sodium 2 ...
17th Expert Committee on the Selection and Use of Essential Medicines Geneva, 2009 Proposal for the inclusion of mesna (sodium 2-mercaptoethane sulfonate) for the prevention of ifosfamide and cyclophosphamide (oxazaphosphorine cytotoxics) induced haemorrhagic cystitis FINAL REPORT Paul A. Carless BHSc, MMedSc.( ) Discipline of Clinical Pharmacology School of Medicine and Public Health Faculty of Health University of Newcastle Level 5, Clinical Sciences Building, NM2 Newcastle Mater Hospital Edith Street, Waratah, 2298 New South Wales AUSTRALIA Tel +61-02-49211726 Fax + 61-02-49602088 WHO EML - Final Report - mesna (sodium 2-mercaptoethane sulfonate) February 2008 11. Summary statement of the Proposal mesna is proposed for the inclusion in the World Health Organisation (WHO) Model List of Essential Medicines for the prevention of oxazaphosphorine-induced (ifosfamide and cyclophosphamide) hemorrhagic cystitis.
17th Expert Committee on the Selection and Use of Essential Medicines Geneva, 2009 Proposal for the inclusion of mesna (sodium 2-mercaptoethane sulfonate) for
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: